Clinical Trial

Study of DS-1001b in Patients With Gene IDH1-Mutated Gliomas

Name: Study of DS-1001b in Patients With Gene IDH1-Mutated Gliomas — clinical trial record (NCT03030066)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Completed Phase 1

View on ClinicalTrials.gov →

Summary

This is a study to assess the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD) and anti-tumor activity of DS-1001b in patients with gliomas that harbor IDH1-R132 mutations.

Protocol Amendment History 2 changes

critical Trial completed 2026-07-29

minor Completion moved earlier: 2026-08-31 -> 2026-07-16 2026-07-29

Trial Details

NCT Number	NCT03030066
Lead Sponsor	Daiichi Sankyo
Conditions	Glioma
Enrollment	47 participants
Start Date	2017-01-19
Primary Completion	2021-01-31 (estimated)
Study Completion	2026-07-16 (estimated)
Updated on ClinicalTrials.gov	2026-07-28